EP3188748A4 - Composition immunogène dirigée contre campylobacter jejuni - Google Patents

Composition immunogène dirigée contre campylobacter jejuni Download PDF

Info

Publication number
EP3188748A4
EP3188748A4 EP15830474.1A EP15830474A EP3188748A4 EP 3188748 A4 EP3188748 A4 EP 3188748A4 EP 15830474 A EP15830474 A EP 15830474A EP 3188748 A4 EP3188748 A4 EP 3188748A4
Authority
EP
European Patent Office
Prior art keywords
immunogenic composition
campylobacter jejuni
composition against
against campylobacter
jejuni
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP15830474.1A
Other languages
German (de)
English (en)
Other versions
EP3188748A1 (fr
Inventor
Patricia Guerry
Mario Artur Monteiro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Navy
Original Assignee
US Department of Navy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Navy filed Critical US Department of Navy
Publication of EP3188748A1 publication Critical patent/EP3188748A1/fr
Publication of EP3188748A4 publication Critical patent/EP3188748A4/fr
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K2039/106—Vibrio; Campylobacter; Not used, see subgroups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6087—Polysaccharides; Lipopolysaccharides [LPS]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP15830474.1A 2014-08-07 2015-07-31 Composition immunogène dirigée contre campylobacter jejuni Pending EP3188748A4 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201462034436P 2014-08-07 2014-08-07
US201462054454P 2014-09-24 2014-09-24
US201562165301P 2015-05-22 2015-05-22
PCT/US2015/043070 WO2016022412A1 (fr) 2014-08-07 2015-07-31 Composition immunogène dirigée contre campylobacter jejuni

Publications (2)

Publication Number Publication Date
EP3188748A1 EP3188748A1 (fr) 2017-07-12
EP3188748A4 true EP3188748A4 (fr) 2018-04-18

Family

ID=55264367

Family Applications (1)

Application Number Title Priority Date Filing Date
EP15830474.1A Pending EP3188748A4 (fr) 2014-08-07 2015-07-31 Composition immunogène dirigée contre campylobacter jejuni

Country Status (5)

Country Link
EP (1) EP3188748A4 (fr)
JP (1) JP6530051B2 (fr)
AU (2) AU2015301368B2 (fr)
CA (1) CA2957430C (fr)
WO (1) WO2016022412A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117347415B (zh) * 2023-09-22 2024-10-01 江苏国源先进仪器技术研究院有限公司 一种基于高场核磁共振技术鉴定多肽药物二硫键的方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005020964A1 (fr) * 2003-06-02 2005-03-10 Chiron Corporation Compositions immunogenes basees sur des microparticules comprenant des antigenes contenant de l'anatoxine adsorbee et des polysaccharides
WO2007038122A2 (fr) * 2005-09-21 2007-04-05 The United States Of America As Represented By The Secretary Of The Navy Composition d'une capsule immunogenique utilisee comme composant d'un vaccin contre campylobacter jejuni
WO2009017666A1 (fr) * 2007-07-27 2009-02-05 The United States Of America As Represented By The Secretary Of The Navy Composition de capsule pour une utilisation en tant qu'immunogène contre campylobacter jejuni

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9308246B2 (en) * 2010-05-28 2016-04-12 The United States Of America As Represented By The Secretary Of The Navy Capsule composition for use as immunogen against Campylobacter jejuni
CA2961883C (fr) * 2014-09-24 2023-10-03 The United States Of America As Represented By The Secretary Of The Navy Construction recombinee combinant les bacteries escherichia coli enterotoxinogene et campylobacter jejuni

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005020964A1 (fr) * 2003-06-02 2005-03-10 Chiron Corporation Compositions immunogenes basees sur des microparticules comprenant des antigenes contenant de l'anatoxine adsorbee et des polysaccharides
WO2007038122A2 (fr) * 2005-09-21 2007-04-05 The United States Of America As Represented By The Secretary Of The Navy Composition d'une capsule immunogenique utilisee comme composant d'un vaccin contre campylobacter jejuni
WO2009017666A1 (fr) * 2007-07-27 2009-02-05 The United States Of America As Represented By The Secretary Of The Navy Composition de capsule pour une utilisation en tant qu'immunogène contre campylobacter jejuni

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
ANDREY V KARLYSHEV ET AL: "Analysis of Campylobacter jejuni Capsular Loci Reveals Multiple Mechanisms for the Generation of Structural Diversity and the Ability to Form Complex Heptoses", MOLECULAR MICROBIOL, WILEY-BLACKWELL PUBLISHING LTD, GB, vol. 55, no. 1, 1 January 2005 (2005-01-01), pages 90 - 103, XP008126621, ISSN: 0950-382X, DOI: 10.1111/J.1365-2958.2004.04374.X *
F. POLY ET AL: "Discrimination of Major Capsular Types of Campylobacter jejuni by Multiplex PCR", JOURNAL OF CLINICAL MICROBIOLOGY, vol. 49, no. 5, 16 March 2011 (2011-03-16), pages 1750 - 1757, XP055069851, ISSN: 0095-1137, DOI: 10.1128/JCM.02348-10 *
MARTINE C. HOLST SØRENSEN ET AL: "Phase Variable Expression of Capsular Polysaccharide Modifications Allows Campylobacter jejuni to Avoid Bacteriophage Infection in Chickens", FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, vol. 2, 20 February 2012 (2012-02-20), pages 1 - 11, XP055429225, DOI: 10.3389/fcimb.2012.00011 *
PAPP-SZABO ET AL: "Cell-surface @a-glucan in Campylobacter jejuni 81-176", CARBOHYDRATE RESE, PERGAMON, GB, vol. 340, no. 13, 26 September 2005 (2005-09-26), pages 2218 - 2221, XP005032116, ISSN: 0008-6215, DOI: 10.1016/J.CARRES.2005.06.023 *
REDKYNA ET AL: "A vaccine against Campylobacter jejuni serotype HS:5", 3 January 2014 (2014-01-03), pages 1 - 101, XP009503578, Retrieved from the Internet <URL:http://hdl.handle.net/10214/7740> *
See also references of WO2016022412A1 *

Also Published As

Publication number Publication date
AU2015301368A1 (en) 2017-02-09
AU2018204255A1 (en) 2018-07-05
WO2016022412A8 (fr) 2017-04-20
CA2957430A1 (fr) 2016-02-11
CA2957430C (fr) 2021-01-12
WO2016022412A1 (fr) 2016-02-11
AU2018204255B2 (en) 2019-04-18
JP2017524710A (ja) 2017-08-31
JP6530051B2 (ja) 2019-06-12
WO2016022412A9 (fr) 2016-05-12
AU2015301368B2 (en) 2018-04-05
EP3188748A1 (fr) 2017-07-12

Similar Documents

Publication Publication Date Title
ZA201702202B (en) Capsule composition
EP3040326A4 (fr) Composition d&#39;halogéno-oléfine
EP3398996A4 (fr) Composition
EP3339331A4 (fr) Composition
EP3281534A4 (fr) Composition édulcorante contenant de l&#39;érythritol
EP3210613A4 (fr) Composition pour application externe
EP3067338A4 (fr) Composition durcissable à l&#39;eau
EP3248475A4 (fr) Composition
EP3221420A4 (fr) Compositions photochromes-électrochromes
EP3221345A4 (fr) Compositions de métalloprotéines
EP3100742A4 (fr) Composition d&#39;agent anticancéreux
EP3287010A4 (fr) Composition destinée à améliorer la texture des aliments
EP3231430A4 (fr) Composition
EP3137629A4 (fr) Compositions et procédés de détection de la maladie du huanglongbing
EP3191110A4 (fr) Composition de polygalacturonan rhamnogalacturonane (pgrg1)
EP3369418A4 (fr) Composition
EP3125321A4 (fr) Composition filmogène organique semi-conductrice
EP3366730A4 (fr) Composition d&#39;encre à base d&#39;eau
EP3228322B8 (fr) Composition d&#39;adjuvant
EP3162223A4 (fr) Composition de boisson
EP3138569A4 (fr) Composition d&#39;application externe
EP3322295A4 (fr) Composition
EP3237399A4 (fr) Composés, compositions et procédés
EP3214161A4 (fr) Composition d&#39;agent de nettoyage
IL249151B (en) A preparation for oral administration

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20170223

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 39/02 20060101ALI20171208BHEP

Ipc: A61K 39/385 20060101ALI20171208BHEP

Ipc: A61K 39/00 20060101AFI20171208BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20180320

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 39/00 20060101AFI20180314BHEP

Ipc: A61K 39/02 20060101ALI20180314BHEP

Ipc: A61K 39/385 20060101ALI20180314BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20200318

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS